Dennis J. Church active positions
| Companies | Position | Start | End |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Corporate Officer/Principal | 2009-11-16 | - |
Career history of Dennis J. Church
Former positions of Dennis J. Church
| Companies | Position | Start | End |
|---|---|---|---|
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - | - |
Statistics
International
| Switzerland | 3 |
Operational
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute |
- Stock Market
- Insiders
- Dennis J. Church
- Experience
